Publication

Article

Cardiology Review® Online

February 2009
Volume26
Issue 2

Counseling may prove effective in patients with CVD risk factors

A 45-year-old woman presented to our institution for cardiovascular risk assessment. The patient had no personal or family history of cardiovascular disease (CVD), but reported smoking 1 pack of cigarettes daily. She noted exercising occasionally without symptomatic limitations.

A 45-year-old woman presented to our institution for cardiovascular risk assessment. The patient had no personal or family history of cardiovascular disease (CVD), but reported smoking 1 pack of cigarettes daily. She noted exercising occasionally without symptomatic limitations.

On physical examination, the patient appeared to be healthy, despite being overweight (body mass index, 28.7 kg/m2). Her blood pressure was 138/75 mm Hg in both arms, and the examination was otherwise normal. Laboratory studies revealed a fasting blood glucose of 94 mg/dL, total cholesterol of 185 mg/dL, and high-density lipoprotein cholesterol of 51 mg/dL. Her serum creatinine was normal. A resting electrocardiogram (ECG) showed nonspecific ST-segment and T-wave abnormalities. The presence of these abnormalities did not prompt additional testing because a high proportion of false-positive ECG abnormalities are known to occur in individuals in the patient’s age range.

Although the patient’s absolute 10-year risk for coronary heart disease was low, her heavy smoking history was associated with a marked increase in her relative CVD risk in the short-term. The patient noted having significant difficulty in stopping smoking in the past, but an extensive discussion with her regarding the marked short-term risks of smoking in women translated into successful smoking cessation over the next 3 months.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
© 2024 MJH Life Sciences

All rights reserved.